Published in Proc Natl Acad Sci U S A on April 12, 2007
Singlet oxygen is the major reactive oxygen species involved in photooxidative damage to plants. Plant Physiol (2008) 2.01
Nonthermal dielectric-barrier discharge plasma-induced inactivation involves oxidative DNA damage and membrane lipid peroxidation in Escherichia coli. Antimicrob Agents Chemother (2011) 1.58
Antimicrobial strategies centered around reactive oxygen species--bactericidal antibiotics, photodynamic therapy, and beyond. FEMS Microbiol Rev (2013) 1.13
Reactive oxygen species and transcript analysis upon excess light treatment in wild-type Arabidopsis thaliana vs a photosensitive mutant lacking zeaxanthin and lutein. BMC Plant Biol (2011) 1.12
Type I and Type II mechanisms of antimicrobial photodynamic therapy: an in vitro study on gram-negative and gram-positive bacteria. Lasers Surg Med (2012) 1.11
Photodynamic therapy with a cationic functionalized fullerene rescues mice from fatal wound infections. Nanomedicine (Lond) (2010) 1.09
Antimicrobial photodynamic therapy for inactivation of biofilms formed by oral key pathogens. Front Microbiol (2014) 0.95
Pulsed diode laser-based singlet oxygen monitor for photodynamic therapy: in vivo studies of tumor-laden rats. J Biomed Opt (2009) 0.95
Fiber-optic singlet oxygen [1O2 (1Delta(g))] generator device serving as a point selective sterilizer. Photochem Photobiol (2010) 0.90
X-ray induced singlet oxygen generation by nanoparticle-photosensitizer conjugates for photodynamic therapy: determination of singlet oxygen quantum yield. Sci Rep (2016) 0.90
Blue light kills Aggregatibacter actinomycetemcomitans due to its endogenous photosensitizers. Clin Oral Investig (2013) 0.89
Photodynamic Efficiency: From Molecular Photochemistry to Cell Death. Int J Mol Sci (2015) 0.87
Bacterial inactivation by a singlet oxygen bubbler: identifying factors controlling the toxicity of (1)O2 bubbles. Environ Sci Technol (2012) 0.87
Photodynamic therapy induces an immune response against a bacterial pathogen. Expert Rev Clin Immunol (2012) 0.82
Fast and effective: intense pulse light photodynamic inactivation of bacteria. J Ind Microbiol Biotechnol (2012) 0.82
Collagen cross-linking for resistant corneal ulcer. Int Ophthalmol (2012) 0.82
Mechanisms for photoinactivation of Enterococcus faecalis in seawater. Appl Environ Microbiol (2012) 0.82
Antimicrobial photodynamic therapy with decacationic monoadducts and bisadducts of [70]fullerene: in vitro and in vivo studies. Nanomedicine (Lond) (2013) 0.81
Bacteriophytochrome controls carotenoid-independent response to photodynamic stress in a non-photosynthetic rhizobacterium, Azospirillum brasilense Sp7. Sci Rep (2012) 0.81
The impact of absorbed photons on antimicrobial photodynamic efficacy. Front Microbiol (2015) 0.81
Potentiation of photoinactivation of Gram-positive and Gram-negative bacteria mediated by six phenothiazinium dyes by addition of azide ion. Photochem Photobiol Sci (2014) 0.80
Photodynamic Therapy for Cancer and for Infections: What Is the Difference? Isr J Chem (2012) 0.79
Fast and effective photodynamic inactivation of multiresistant bacteria by cationic riboflavin derivatives. PLoS One (2014) 0.78
Potassium Iodide Potentiates Broad-Spectrum Antimicrobial Photodynamic Inactivation Using Photofrin. ACS Infect Dis (2017) 0.77
Evaluation of the Effects of Photodynamic Therapy Alone and Combined with Standard Antifungal Therapy on Planktonic Cells and Biofilms of Fusarium spp. and Exophiala spp. Front Microbiol (2016) 0.76
Singlet oxygen detection in biological systems: Uses and limitations. Plant Signal Behav (2016) 0.76
Potential Effects of Corneal Cross-Linking upon the Limbus. Biomed Res Int (2016) 0.75
Lactobacilli enhance reactive oxygen species-dependent apoptosis-inducing signaling. Redox Biol (2017) 0.75
Potassium iodide potentiates antimicrobial photodynamic inactivation mediated by Rose Bengal: in vitro and in vivo studies. Antimicrob Agents Chemother (2017) 0.75
Antimicrobial effect of blue light using Porphyromonas gingivalis pigment. Sci Rep (2017) 0.75
Molecular basis of bacterial outer membrane permeability. Microbiol Rev (1985) 17.75
Diffusion of beta-lactam antibiotics through the porin channels of Escherichia coli K-12. Antimicrob Agents Chemother (1985) 4.88
Photodynamic therapy: a new antimicrobial approach to infectious disease? Photochem Photobiol Sci (2004) 4.60
The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. J Antimicrob Chemother (1998) 2.60
Lipid peroxidation, oxygen radicals, cell damage, and antioxidant therapy. Lancet (1984) 2.53
The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen. Photochem Photobiol (1991) 2.50
Physical mechanisms of generation and deactivation of singlet oxygen. Chem Rev (2003) 2.26
Direct near-infrared luminescence detection of singlet oxygen generated by photodynamic therapy in cells in vitro and tissues in vivo. Photochem Photobiol (2002) 1.90
Photodynamic inactivation of Gram-negative bacteria: problems and possible solutions. J Photochem Photobiol B (1992) 1.86
Meso-substituted cationic porphyrins as efficient photosensitizers of gram-positive and gram-negative bacteria. J Photochem Photobiol B (1996) 1.83
Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors. Cancer Res (2004) 1.80
Definition of type I and type II photosensitized oxidation. Photochem Photobiol (1991) 1.75
Inactivation of gram-negative bacteria by photosensitized porphyrins. Photochem Photobiol (1992) 1.50
Studies on the mechanism of bacteria photosensitization by meso-substituted cationic porphyrins. J Photochem Photobiol B (1996) 1.50
Susceptibility of Streptococcus mutans biofilms to photodynamic therapy: an in vitro study. J Antimicrob Chemother (2005) 1.40
Photoinactivation of bacteria. Use of a cationic water-soluble zinc phthalocyanine to photoinactivate both gram-negative and gram-positive bacteria. J Photochem Photobiol B (1996) 1.36
Photo-oxidative killing of human colonic cancer cells using indocyanine green and infrared light. Br J Cancer (1999) 1.33
Photodynamic effects of novel XF porphyrin derivatives on prokaryotic and eukaryotic cells. Antimicrob Agents Chemother (2005) 1.31
Singlet oxygen generation by UVA light exposure of endogenous photosensitizers. Biophys J (2006) 1.24
Indocyanine green: intracellular uptake and phototherapeutic effects in vitro. J Photochem Photobiol B (1997) 1.22
Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro. Phys Med Biol (2005) 1.18
Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate. Cancer Res (2000) 1.17
Antimicrobial resistance in Staphylococcus aureus at the University of Chicago Hospitals: a 15-year longitudinal assessment in a large university-based hospital. Infect Control Hosp Epidemiol (2003) 1.12
Structure-activity relationship of porphines for photoinactivation of bacteria. Photochem Photobiol (1995) 1.07
Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. A pilot dose-ranging study. Arch Dermatol (1997) 1.06
Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome. Br J Dermatol (2004) 1.04
Enhancement of erythrosine-mediated photodynamic therapy of Streptococcus mutans biofilms by light fractionation. J Antimicrob Chemother (2006) 1.02
Cardiac performance as a function of intracellular oxygen tension in buffer-perfused hearts. Am J Physiol Heart Circ Physiol (2001) 1.01
Sensitivity of Candida albicans germ tubes and biofilms to photofrin-mediated phototoxicity. Antimicrob Agents Chemother (2005) 0.96
Photodynamic action of merocyanine 540 on artificial and natural cell membranes: involvement of singlet molecular oxygen. Proc Natl Acad Sci U S A (1987) 0.95
Direct detection of singlet oxygen generated by UVA irradiation in human cells and skin. J Invest Dermatol (2007) 0.92
Inactivation of anaerobic bacteria by various photosensitized porphyrins or by hemin. Curr Microbiol (1994) 0.89
In vitro and in vivo photosensitization by protoporphyrins possessing different lipophilicities and vertical localization in the membrane. Photochem Photobiol (2007) 0.88
In vivo effects of porphyrins on bacterial DNA. J Photochem Photobiol B (1991) 0.87
Antibiotic uptake and transport by bacteria. Scand J Infect Dis Suppl (1990) 0.86
Time-resolved investigations of singlet oxygen luminescence in water, in phosphatidylcholine, and in aqueous suspensions of phosphatidylcholine or HT29 cells. J Phys Chem B (2005) 0.86
Antagonistic effects of combination photosensitization by hypericin, meso-tetrahydroxyphenylchlorin (mTHPC) and photofrin II on Staphylococcus aureus. Drugs Exp Clin Res (1999) 0.85
Choice of optimal wavelength for PDT: the significance of oxygen depletion. Photochem Photobiol (2005) 0.84
Dependence of photosensitized singlet oxygen production on porphyrin structure and solvent. Prog Clin Biol Res (1984) 0.83
Direct observation of singlet oxygen phosphorescence at 1270 nm from L1210 leukemia cells exposed to polyporphyrin and light. Arch Biochem Biophys (1991) 0.83
Primary clinical response and long-term follow-up of solar keratoses treated with topically applied 5-aminolevulinic acid and irradiation by different wave bands of light. J Photochem Photobiol B (1997) 0.83
Circulatory oxygen transport in the water flea Daphnia magna. J Comp Physiol B (2002) 0.82
Singlet oxygen generation by Photofrin in homogeneous and light-scattering media. J Photochem Photobiol B (1994) 0.79
Collapse of K+ and ionic balance during photodynamic inactivation of leukemic cells, erythrocytes and Staphylococcus aureus. Int J Biochem (1993) 0.78
[Treatment of pediatric hemangiomas with the flashlamp-pumped pulsed dye laser]. Hautarzt (1996) 0.77
Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet. J Am Acad Dermatol (2003) 4.15
Non-melanoma skin cancer. Lancet (2010) 4.11
Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell. J Invest Dermatol (2013) 2.31
Foreign body granulomas caused by polymethylmethacrylate microspheres: successful treatment with allopurinol. Arch Dermatol (2003) 2.23
Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers. Clin Chem (2004) 2.17
Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome. Nat Genet (2012) 2.03
Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol (2007) 2.03
Cutaneous amyloidoses and systemic amyloidoses with cutaneous involvement. Eur J Dermatol (2010) 2.03
Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation pattern. Proc Natl Acad Sci U S A (2007) 1.97
Treatment of oral lichen planus with the 308-nm UVB excimer laser--early preliminary results in eight patients. Lasers Surg Med (2003) 1.79
Mosaicism of activating FGFR3 mutations in human skin causes epidermal nevi. J Clin Invest (2006) 1.78
Tattoo pigments are cleaved by laser light-the chemical analysis in vitro provide evidence for hazardous compounds. Photochem Photobiol (2004) 1.66
Tattooing of skin results in transportation and light-induced decomposition of tattoo pigments--a first quantification in vivo using a mouse model. Exp Dermatol (2009) 1.55
Whole-body UVB irradiation during allogeneic hematopoietic cell transplantation is safe and decreases acute graft-versus-host disease. J Invest Dermatol (2011) 1.51
Daylight photodynamic therapy for actinic keratoses in São Paulo, Brazil. Photodermatol Photoimmunol Photomed (2014) 1.48
Cutaneous metastases of visceral tumours: a review. J Cancer Res Clin Oncol (2008) 1.45
Granulomatous jellyfish dermatitis. J Dtsch Dermatol Ges (2007) 1.43
Dysplastic melanocytic nevi of the lower leg: sex- and site-specific histopathology. Am J Dermatopathol (2010) 1.40
Keratinocytic epidermal nevi are associated with mosaic RAS mutations. J Med Genet (2012) 1.40
Intense pulsed light (IPL): a review. Lasers Surg Med (2010) 1.39
Update on hemangiomas and vascular malformations of the head and neck. Eur Arch Otorhinolaryngol (2008) 1.39
[Smoking -- effects on the skin]. J Dtsch Dermatol Ges (2003) 1.38
Gene expression profiling of melanocytes following Q-Switched Ruby laser irradiation. Dermatology (2008) 1.37
Dead Sea treatment - principle for outpatient use in atopic dermatitis: safety and efficacy of synchronous balneophototherapy using narrowband UVB and bathing in Dead Sea salt solution. Eur J Dermatol (2002) 1.37
High frequency of FGFR3 mutations in adenoid seborrheic keratoses. J Invest Dermatol (2006) 1.37
Pityriasis rubra pilaris: a review of diagnosis and treatment. Am J Clin Dermatol (2010) 1.31
Light-induced decomposition of indocyanine green. Invest Ophthalmol Vis Sci (2008) 1.29
Singlet oxygen generation by UVA light exposure of endogenous photosensitizers. Biophys J (2006) 1.24
RBP2-H1/JARID1B is a transcriptional regulator with a tumor suppressive potential in melanoma cells. Int J Cancer (2008) 1.22
Plasma medicine: possible applications in dermatology. J Dtsch Dermatol Ges (2010) 1.21
Antiangiogenetic therapy with pioglitazone, rofecoxib, and metronomic trofosfamide in patients with advanced malignant vascular tumors. Cancer (2003) 1.20
Expression profile of Eph receptors and ephrin ligands in human skin and downregulation of EphA1 in nonmelanoma skin cancer. Mod Pathol (2006) 1.20
Retinoblastoma-binding protein 2-homolog 1: a retinoblastoma-binding protein downregulated in malignant melanomas. Mod Pathol (2005) 1.16
Antibacterial photodynamic therapy in dermatology. Photochem Photobiol Sci (2004) 1.16
Incidence of health problems associated with tattooed skin: a nation-wide survey in German-speaking countries. Dermatology (2010) 1.14
Spectrum of FGFR3 mutations in multiple intraindividual seborrheic keratoses. J Invest Dermatol (2007) 1.13
Orofacial granulomatosis as the initial presentation of Crohn's disease in an adolescent. Dermatology (2003) 1.12
Selective photothermolysis of blood vessels following flashlamp-pumped pulsed dye laser irradiation: in vivo results and mathematical modelling are in agreement. J Invest Dermatol (2005) 1.12
Photodynamic therapy in dermatology. Eur J Dermatol (2006) 1.11
Re-expression of the retinoblastoma-binding protein 2-homolog 1 reveals tumor-suppressive functions in highly metastatic melanoma cells. J Invest Dermatol (2006) 1.10
A new mathematical approach to the diffusion approximation theory for selective photothermolysis modeling and its implication in laser treatment of port-wine stains. Lasers Surg Med (2004) 1.09
Photodynamic therapy in dermatology--an update. Photodermatol Photoimmunol Photomed (2005) 1.09
Wound healing in the 21st century. J Am Acad Dermatol (2010) 1.07
Simultaneous photographing of oxygen and pH in vivo using sensor films. Angew Chem Int Ed Engl (2011) 1.07
A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts. PLoS One (2012) 1.07
Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant Melanoma. PPAR Res (2009) 1.06
Loss of EphB6 expression in metastatic melanoma. Int J Oncol (2003) 1.06
Adverse reactions after tattooing: review of the literature and comparison to results of a survey. Dermatology (2013) 1.06
Targeted combined anti-inflammatory and angiostatic therapy in advanced melanoma: a randomized phase II trial. Melanoma Res (2007) 1.06
In vivo confocal scanning laser microscopy in dermatology. Lasers Med Sci (2006) 1.03
2D luminescence imaging of pH in vivo. Proc Natl Acad Sci U S A (2011) 1.03
Activation of the PI3K/AKT pathway in Merkel cell carcinoma. PLoS One (2012) 1.02
Fibroadenoma of the axilla. Dermatol Surg (2005) 1.02
Heat shock protein 70 membrane expression and melanoma-associated marker phenotype in primary and metastatic melanoma. Melanoma Res (2003) 1.01
Multiple oncogenic mutations and clonal relationship in spatially distinct benign human epidermal tumors. Proc Natl Acad Sci U S A (2010) 1.00
Ephrin-B2 overexpression enhances integrin-mediated ECM-attachment and migration of B16 melanoma cells. Int J Oncol (2005) 0.99
Leg ulcers and abscesses caused by Serratia marcescens. Eur J Dermatol (2008) 0.99
Self-adhesive thin films for topical delivery of 5-aminolevulinic acid. Eur J Pharm Biopharm (2002) 0.99
IgE-mediated anaphylactic reaction induced by succinate ester of methylprednisolone. Ann Allergy Asthma Immunol (2002) 0.99
Photodynamic therapy in dermatology: state-of-the-art. Photodermatol Photoimmunol Photomed (2010) 0.99
The -2518 promotor polymorphism in the MCP-1 gene is associated with systemic sclerosis. J Invest Dermatol (2005) 0.98
Mathematical modeling of selective photothermolysis to aid the treatment of vascular malformations and hemangioma with pulsed dye laser. Lasers Med Sci (2007) 0.97
Fluorescence induction of protoporphyrin IX by a new 5-aminolevulinic acid nanoemulsion used for photodynamic therapy in a full-thickness ex vivo skin model. Exp Dermatol (2010) 0.96
Ephrin-B2 is differentially expressed in the intestinal epithelium in Crohn's disease and contributes to accelerated epithelial wound healing in vitro. World J Gastroenterol (2005) 0.96
Penetration enhancement of two topical 5-aminolaevulinic acid formulations for photodynamic therapy by erbium:YAG laser ablation of the stratum corneum: continuous versus fractional ablation. Exp Dermatol (2010) 0.95
Influence of 5-aminolevulinic acid and red light on collagen metabolism of human dermal fibroblasts. J Invest Dermatol (2003) 0.95
Successful treatment of cutaneous sarcoidosis using topical photodynamic therapy. Arch Dermatol (2002) 0.94
Progressive hyperpigmentation and generalized lentiginosis without associated systemic symptoms: a rare hereditary pigmentation disorder in south-east Germany. Acta Derm Venereol (2004) 0.94
Confocal laser scanning microscopy--evaluation of native tissue sections in micrographic surgery. Lasers Med Sci (2009) 0.94
Targeting T cells to hit B cells: successful treatment of cutaneous plasmacytosis with topical pimecrolimus. Dermatology (2006) 0.94
Photodynamic inactivation of multi-resistant bacteria (PIB) - a new approach to treat superficial infections in the 21st century. J Dtsch Dermatol Ges (2010) 0.94
Results of nonablative wrinkle reduction with a 1,450-nm diode laser: difficulties in the assessment of "subtle changes". Lasers Surg Med (2005) 0.93
Refinement of the x-ray structure of the RC LH1 core complex from Rhodopseudomonas palustris by single-molecule spectroscopy. Proc Natl Acad Sci U S A (2007) 0.93
Modern tattoos cause high concentrations of hazardous pigments in skin. Contact Dermatitis (2008) 0.93
Direct detection of singlet oxygen generated by UVA irradiation in human cells and skin. J Invest Dermatol (2007) 0.92